- Braxia Scientific Announces Board Appointment
- Braxia Scientific Announces Court Approval of Class Action Settlement in Canada
- Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home
- Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022
- Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients
- Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.
- Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results
- Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Industry Leader as VP R&D and Growth
Braxia Scientific Corp (4960:STU) closed at 0.0392, 29.80% above the 52 week low of 0.0302 set on Mar 22, 2022.
0.0302Mar 22 20220.1551Sep 27 2021
Markit short selling activity
|Market cap||10.11m CAD|
|EPS (TTM)||-0.0649 |
Data delayed at least 15 minutes, as of Sep 26 2022.